MedPath

Study of Therapeutic Effects of Sertraline, Flouxetine, Paroxetine and Citalopram in Premature Ejaculatio

Phase 3
Recruiting
Conditions
Premature Ejaculation.
Premature ejaculation
Registration Number
IRCT20180401039167N2
Lead Sponsor
Artesh University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
480
Inclusion Criteria

Male with Premature Ejaculation
Possible at least Once Coitus a Week
Age between 20 to 75 years

Exclusion Criteria

Norologic Disorder
Age Less than 20 and Over 75 Years
Psycologic Disorder
History of Pelvic Surgery
Urinary and Genital Infection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time of Ejaculation ( From Vaginal Entrance to Ejaculation ). Timepoint: The Time of Ejaculation at the Beginning of the Study ( Before the Intervention) and 4 and 8 weeks after the start of Drug. Method of measurement: Measure the time in seconds by the stopwatch by the patient's wife.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath